5-(4-(1-(difluoromethyl)-3,5-dimethyl-1H-pyrazol-4-yl)-2-methylphenyl)-N-(imidazo[1,2-a]pyridin-6-ylmethyl)-N-methyl-1,3,4-oxadiazol-2-amine

ID: ALA4877985

PubChem CID: 164628979

Max Phase: Preclinical

Molecular Formula: C24H23F2N7O

Molecular Weight: 463.49

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(-c2c(C)nn(C(F)F)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1

Standard InChI:  InChI=1S/C24H23F2N7O/c1-14-11-18(21-15(2)30-33(16(21)3)23(25)26)6-7-19(14)22-28-29-24(34-22)31(4)12-17-5-8-20-27-9-10-32(20)13-17/h5-11,13,23H,12H2,1-4H3

Standard InChI Key:  BWGPQCFMXBFDLN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   13.8382  -24.8599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8382  -24.0327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5463  -23.6182    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2584  -24.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2584  -24.8599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5463  -25.2683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9723  -25.2736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6875  -24.8621    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.4014  -25.2756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4853  -26.0961    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2919  -26.2689    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.7056  -25.5549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1543  -24.9411    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.5262  -25.4698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0079  -26.1392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8278  -26.0545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1652  -25.3006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6765  -24.6307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8583  -24.7187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3716  -24.0524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9857  -25.2144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5373  -25.8267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2910  -25.4911    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.2048  -24.6704    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.3978  -24.4990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0618  -23.7455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8179  -24.1184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6026  -24.3733    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   23.6464  -23.3114    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   22.3659  -26.6336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6875  -24.0370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3711  -22.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5545  -22.7357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2253  -23.4873    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  0
  4  3  1  0
  5  4  2  0
  6  5  1  0
  1  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 19 20  1  0
 17 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 21  2  0
 25 26  1  0
 24 27  1  0
 27 28  1  0
 27 29  1  0
 22 30  1  0
  8 31  1  0
  3 32  1  0
 32 33  2  0
 33 34  1  0
 34  2  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4877985

    ---

Associated Targets(Human)

MERTK Tchem Proto-oncogene tyrosine-protein kinase MER (2687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AXL Tchem Tyrosine-protein kinase receptor UFO (3469 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT3 Tclin Tyrosine-protein kinase receptor FLT3 (13481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 463.49Molecular Weight (Monoisotopic): 463.1932AlogP: 5.20#Rotatable Bonds: 6
Polar Surface Area: 77.28Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.32CX LogP: 4.13CX LogD: 4.10
Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.34Np Likeness Score: -1.71

References

1. McCoull W, Boyd S, Brown MR, Coen M, Collingwood O, Davies NL, Doherty A, Fairley G, Goldberg K, Hardaker E, He G, Hennessy EJ, Hopcroft P, Hodgson G, Jackson A, Jiang X, Karmokar A, Lainé AL, Lindsay N, Mao Y, Markandu R, McMurray L, McLean N, Mooney L, Musgrove H, Nissink JWM, Pflug A, Reddy VP, Rawlins PB, Rivers E, Schimpl M, Smith GF, Tentarelli S, Travers J, Troup RI, Walton J, Wang C, Wilkinson S, Williamson B, Winter-Holt J, Yang D, Zheng Y, Zhu Q, Smith PD..  (2021)  Optimization of an Imidazo[1,2-a]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with In Vivo Efficacy.,  64  (18.0): [PMID:34478292] [10.1021/acs.jmedchem.1c00920]

Source